Treating Together cover art

All Episodes

Treating Together — 93 episodes

#
Title
1

S8 Ep3: Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing

2

S8 Ep2: Radiation Oncology's Financial Squeeze with Dr Ryan Funk

3

S8 Ep1: Gynecologic Cancer Trends, Testing, and Treatment Advances Explained

4

S7 Ep19: AI in Oncology: Managing Information Overload for Trainees and Patients

5

S7 Ep18: Drowning in Data: How Oncologists Are Coping with Information Overload in the AI Era

6

S7 Ep17: Navigating the 505(b)(2) Pathway: Operational, Clinical, and Economic Strategies for Oncology Practices

7

S7 Ep16: ASCO 2026 Preview: Late-Breaking Abstracts Poised to Reshape the Treatment Landscape

8

S7 Ep15: Pediatric Blood Cancers: Building Better Outcomes Through Bold Science

9

S7 Ep14: Choosing Wisely in CLL: A Deep Dive Into Frontline Treatment

10

S7 Ep13: Leveraging AI, Social Media, and Virtual Care in the Information Age

11

S7 Ep12: Beyond Monotherapy: Mechanisms and Combination Strategies in NPM1-Mutant Acute Myeloid Leukemia

12

S7 Ep11: Treating Together: Navigating Treatment Decisions in Relapsed NPM1-Mutant AML: Practical Insights for Clinical Care

13

S7 Ep10: Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies

14

S7 Ep9: Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC

15

S7 Ep8: Precision Hope: The New Frontier of AI-Driven Oncology

16

S7 Ep7: Community Oncology at a Crossroads: Navigating Policy, Progress, and Practice

17

S7 Ep6: Navigating the Future of CLL Care

18

S7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi

19

S7 Ep4: Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD

20

S7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers

21

S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access

22

S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making

23

S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning

24

S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall

25

S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain

26

S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

27

S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

28

S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research

29

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

30

S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology

31

S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer

32

S5 Ep16: Foran Goes Beyond the Basics of BPDCN

33

S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

34

S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel

35

S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US

36

S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role

37

S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine

38

S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM

39

S5 Ep9: Unlocking the Potential of Technology in Community Oncology

40

S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology

41

S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches

42

S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding

43

S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC

44

S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

45

S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing

46

S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC

47

S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer

48

S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care

49

S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities

50

S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC

51

S4 Ep17: Bridging Science and Compassion in Cancer Care

52

S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer

53

S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

54

S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC

55

S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment

56

S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer

57

S4 Ep11: Social Determinants of Health Impacting Oncology Today

58

S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers

59

S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy

60

S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer

61

S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia

62

S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium

63

S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma

64

S4 Ep4: Understanding and Treating Mucosal Melanoma

65

S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer

66

S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment

67

S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers

68

S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment

69

S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment

70

S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer

71

S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting

72

S3 Ep7: The Evolution of Endometrial Cancer Treatment

73

S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm

74

S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment

75

S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia

76

S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management

77

S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma

78

S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma

79

S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach

80

S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer

81

S2 Ep8: New Targeted Therapies in Renal Cell Carcinoma

82

S2 Ep7: Recent Developments in Immunotherapy for Melanoma

83

S2 Ep6: Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal Cancer

84

S2 Ep5: Advancing the Treatment of Cervical and Endometrial Cancers

85

S2 Ep4: Special Episode: Oncology After COVID-19

86

S2 Ep3: Modern Strategies Improving Immunotherapy in Cancer

87

S2 Ep2: The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer

88

S2 Ep1: Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer

89

S1 Ep5: COVID-19 Leaves Its Mark on Oncology Care

90

S1 Ep4: Prostate Cancer Sees Surge of PARP Inhibition Strategies

91

S1 Ep3: Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss

92

S1 Ep2: Precision Medicine Guiding Ovarian Cancer Treatment

93

S1 Ep1: Individualizing Immunotherapy in Non–Small Cell Lung Cancer